ARTICLE | Clinical News
Zilver PTX Drug-Eluting Stent regulatory update
October 24, 2011 7:00 AM UTC
FDA's Circulatory System Devices Panel unanimously recommended approval of Zilver PTX Drug-Eluting Stent from Cook Medical Inc. to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA). The company said it expects FDA action on the stent in early 2012. The panel is part of the Medical Devices Advisory Committee. Cook Medical is part of Cook Group. ...